The global lansoprazole market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). Lansoprazole is one of the proton pump inhibitor drugs that inhibits the stomach from releasing excess gastric acid so as to enable the treatment of numerous gastric disorders. Lansoprazole treats gastroesophageal reflux disease (GERD), which is a disorder resulting in the backward flow of gastric acid from the stomach, leading to symptoms such as heartburn and acidity. The market growth is majorly attributable to the growing prevalence of various gastric disorders such as GERD, gastritis, stomach ulcer, and so on, among the global population. Further the availability of lansoprazole drug as over-the-counter drugs (OTC) apart from the prescription brands in various forms, is also likely to spur the global lansoprazole market. Adding to this, ongoing clinical trials for the analysis of new formulations of lansoprazole with increased drug efficiency is another key factor driving the global lansoprazole market during the forecast period.
Some key players operating in the market include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd., among others. These players are eyeing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships and collaborations, new product launches and development in the existing product portfolio, and so on. For instance, in September 2019, Dr. Reddy’s Laboratories Ltd. announced the launch of Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter (OTC) store-brand equivalent of Prevacid 24HR Capsules, in the US market, as approved by the US Food and Drug Administration (USFDA).
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Lansoprazole Market at: https://orionmarketreports.com/request-sample/?id=98221&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Product Type
- By Distribution Channel
- Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
A full report of Global Lansoprazole Market is available at: https://orionmarketreports.com/global-lansoprazole-market/98221/
Global Lansoprazole Market Report by Segment
By Product Type
- OD Tablets
- Capsules
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies and Drug Stores
Global Lansoprazole Market Report by Region
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East and Africa
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
